These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 24262076)

  • 1. The complexity of intestinal permeability: Assigning the correct BCS classification through careful data interpretation.
    Zur M; Hanson AS; Dahan A
    Eur J Pharm Sci; 2014 Sep; 61():11-7. PubMed ID: 24262076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The low/high BCS permeability class boundary: physicochemical comparison of metoprolol and labetalol.
    Zur M; Gasparini M; Wolk O; Amidon GL; Dahan A
    Mol Pharm; 2014 May; 11(5):1707-14. PubMed ID: 24735251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The biopharmaceutics of successful controlled release drug product: Segmental-dependent permeability of glipizide vs. metoprolol throughout the intestinal tract.
    Zur M; Cohen N; Agbaria R; Dahan A
    Int J Pharm; 2015 Jul; 489(1-2):304-10. PubMed ID: 25957705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-situ intestinal rat perfusions for human Fabs prediction and BCS permeability class determination: Investigation of the single-pass vs. the Doluisio experimental approaches.
    Lozoya-Agullo I; Zur M; Wolk O; Beig A; González-Álvarez I; González-Álvarez M; Merino-Sanjuán M; Bermejo M; Dahan A
    Int J Pharm; 2015 Mar; 480(1-2):1-7. PubMed ID: 25595387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional intestinal drug permeation: biopharmaceutics and drug development.
    Lennernäs H
    Eur J Pharm Sci; 2014 Jun; 57():333-41. PubMed ID: 23988845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional-dependent intestinal permeability and BCS classification: elucidation of pH-related complexity in rats using pseudoephedrine.
    Fairstein M; Swissa R; Dahan A
    AAPS J; 2013 Apr; 15(2):589-97. PubMed ID: 23440549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-permeability criterion for BCS classification: segmental/pH dependent permeability considerations.
    Dahan A; Miller JM; Hilfinger JM; Yamashita S; Yu LX; Lennernäs H; Amidon GL
    Mol Pharm; 2010 Oct; 7(5):1827-34. PubMed ID: 20701326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biowaiver monographs for immediate-release solid oral dosage forms: codeine phosphate.
    Dahan A; Wolk O; Zur M; Amidon GL; Abrahamsson B; Cristofoletti R; Groot DW; Kopp S; Langguth P; Polli JE; Shah VP; Dressman JB
    J Pharm Sci; 2014 Jun; 103(6):1592-600. PubMed ID: 24788239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the full potential of the biopharmaceutics classification system reached?
    Bergström CA; Andersson SB; Fagerberg JH; Ragnarsson G; Lindahl A
    Eur J Pharm Sci; 2014 Jun; 57():224-31. PubMed ID: 24075971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. pH-Dependent solubility and permeability criteria for provisional biopharmaceutics classification (BCS and BDDCS) in early drug discovery.
    Varma MV; Gardner I; Steyn SJ; Nkansah P; Rotter CJ; Whitney-Pickett C; Zhang H; Di L; Cram M; Fenner KS; El-Kattan AF
    Mol Pharm; 2012 May; 9(5):1199-212. PubMed ID: 22489626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biopharmaceutics classification and intestinal absorption study of apigenin.
    Zhang J; Liu D; Huang Y; Gao Y; Qian S
    Int J Pharm; 2012 Oct; 436(1-2):311-7. PubMed ID: 22796171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Segmental dependent transport of low permeability compounds along the small intestine due to P-glycoprotein: the role of efflux transport in the oral absorption of BCS class III drugs.
    Dahan A; Amidon GL
    Mol Pharm; 2009; 6(1):19-28. PubMed ID: 19248230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro solubility, dissolution and permeability studies combined with semi-mechanistic modeling to investigate the intestinal absorption of desvenlafaxine from an immediate- and extended release formulation.
    Franek F; Jarlfors A; Larsen F; Holm P; Steffansen B
    Eur J Pharm Sci; 2015 Sep; 77():303-13. PubMed ID: 26091569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
    Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A modified physiological BCS for prediction of intestinal absorption in drug discovery.
    Zaki NM; Artursson P; Bergström CA
    Mol Pharm; 2010 Oct; 7(5):1478-87. PubMed ID: 20734997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-based prediction of human intestinal membrane permeability for rapid in silico BCS classification.
    Sun L; Liu X; Xiang R; Wu C; Wang Y; Sun Y; Sun J; He Z
    Biopharm Drug Dispos; 2013 Sep; 34(6):321-35. PubMed ID: 23716273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biopharmaceutics classification of puerarin and comparison of perfusion approaches in rats.
    Li H; Dong L; Liu Y; Wang G; Wang G; Qiao Y
    Int J Pharm; 2014 May; 466(1-2):133-8. PubMed ID: 24607203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biopharmaceutics classification and intestinal absorption of chikusetsusaponin IVa.
    Zhang W; Liu H; Liu C
    Biopharm Drug Dispos; 2019 Sep; 40(8):276-281. PubMed ID: 31294470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BCS Class IV Oral Drugs and Absorption Windows: Regional-Dependent Intestinal Permeability of Furosemide.
    Markovic M; Zur M; Ragatsky I; Cvijić S; Dahan A
    Pharmaceutics; 2020 Dec; 12(12):. PubMed ID: 33276565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The suitability of an in situ perfusion model for permeability determinations: utility for BCS class I biowaiver requests.
    Kim JS; Mitchell S; Kijek P; Tsume Y; Hilfinger J; Amidon GL
    Mol Pharm; 2006; 3(6):686-94. PubMed ID: 17140256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.